Health Policy and Regulation
by Laura DeStefano | Jul 27, 2012 | Commentary, Perspectives
American health care faces challenges in access, cost, and quality and in marked geographic and socioeconomic variability. While these challenges will require actions by federal and state governments, they also call for action by individual health systems. Actions by...
by Laura DeStefano | Jul 26, 2012 | Discussion Paper, Perspectives
Health care costs have doubled as a share of the economy over the past three decades (Martin et al., 2012), causing stress on family, employer, and government budgets. Furthermore, these expenses contain substantial waste and often do not improve patient health. One...
by Laura DeStefano | Jul 13, 2012 | Commentary, Perspectives
The policy drivers behind meaningful use are improving quality, enhancing safety, and increasing efficiency in our health care system. In my view, health care in the United States lacks “systemness”—instead relying on disconnected hospitals, clinician offices, labs,...
by Laura DeStefano | Jun 29, 2012 | Commentary, Perspectives
During the first decade of this century, the Institute of Medicine (IOM) played a major role in laying out a vision and strategic direction for change at all levels of the health system, including patients engaged as partners in their health and health care;...
by Laura DeStefano | Jun 15, 2012 | Commentary, Perspectives
For decades, using electronic health records (EHRs) and exchanging health information has been viewed as essential for modernizing health care and improving patient care. The 2009 Health Information Technology for Economic and Clinical Health (HITECH) Act provided...
by Laura DeStefano | Jun 5, 2012 | Discussion Paper, Perspectives
As leaders of health care organizations, we are acutely aware of the pressures that rising health care costs place on individuals, employers, and the government, as we are of unacceptable shortfalls in the quality and efficiency of care. But we have also learned,...
by Laura DeStefano | May 18, 2012 | Commentary, Perspectives
The Institute of Medicine’s (IOM’s) release of the reports To Err is Human and Crossing the Quality Chasm in 1999 and 2001, respectively, were markers of a tipping point in U.S. health care. Prior to that time, “quality” in health care had largely been defined by...
by Laura DeStefano | May 18, 2012 | Discussion Paper, Perspectives
In Canada, as elsewhere, the translation of health research outcomes to development of products and services for health care and final implementation in patients does not progress as rapidly, efficiently, or successfully as it should. In order to address this problem,...
by Laura DeStefano | May 18, 2012 | Discussion Paper, Perspectives
The arrangements for the regulation and governance of health research in the United Kingdom (UK) have evolved, piecemeal, over the past 30 years, and much is now enshrined in UK and European Union (EU) legislation. Each individual measure was introduced with the best...
by Laura DeStefano | May 11, 2012 | Discussion Paper, Perspectives
Introduction Clinical trials in the United States have a rich history of involving academic, industry, and government institutions (e.g. the National Institutes of Health [NIH]) to address important medical questions. Nonetheless, over time, clinical trials in the...
Page 16 of 17« First«...10...1314151617»
